U.S. Healthtech Stock News

NYSE:CF
NYSE:CFChemicals

CF Industries Faces DOJ Scrutiny And Questions Over Fertilizer Pricing Power

Senator Josh Hawley has accused CF Industries Holdings (NYSE:CF) of price gouging in its fertilizer business. He has urged the US Department of Justice to pursue an antitrust investigation into the company’s pricing practices. The DOJ is now examining whether CF Industries' fertilizer pricing has harmed farmers and competition. This scrutiny adds legal and political risk in addition to prior attention on fertilizer supply, costs, and global trade disruptions. CF Industries is a major...
NasdaqGS:DOCU
NasdaqGS:DOCUSoftware

A Look At DocuSign (DOCU) Valuation As AI Upgrades And Pricing Changes Draw Focus Before Earnings

Board refresh and AI focus draw attention ahead of DocuSign earnings DocuSign (DOCU) heads into its upcoming fourth quarter fiscal 2026 earnings report with several fresh storylines, including a new independent director appointment and expanding AI driven agreement tools. The company recently added Brian Roberts to its board as an independent Class I director, while also rolling out Iris powered features, testing new eSignature Professional pricing, and partnering with Anthropic on AI...
NasdaqGS:TTEK
NasdaqGS:TTEKCommercial Services

Is Tetra Tech (TTEK) Attractive After Recent Share Price Pullback And Mixed Valuation Signals

If you are wondering whether Tetra Tech shares are offering fair value right now, this article walks through what the current price could mean for long term investors. The stock last closed at US$32.18, with a 7.7% decline over the past week, a 20.4% decline over the past month, and returns of 11.3% over 1 year, 17.9% over 3 years, and 28.8% over 5 years. Recent coverage has focused on Tetra Tech as a US listed commercial services company and on how its current share price compares with...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Is Rezdiffra’s Near‑US$1 Billion Debut Reshaping The Investment Case For Madrigal Pharmaceuticals (MDGL)?

Madrigal Pharmaceuticals recently reported that its MASH drug Rezdiffra generated nearly US$1.00 billion in its first full year on the market, reinforcing the company’s leading position in this disease area. This rapid commercial traction, coupled with management’s expectation for continued robust net sales growth in 2026, has attracted heightened attention from both institutional investors and short-sellers. Next, we’ll examine how Rezdiffra’s nearly US$1.00 billion first-year sales...
NYSE:PIPR
NYSE:PIPRCapital Markets

Assessing Piper Sandler (PIPR) After Recent Share Price Weakness And Capital Markets Activity

If you are wondering whether Piper Sandler Companies' current share price really reflects its underlying worth, or if the recent run leaves room for value, this article walks through that question step by step. The stock last closed at US$282.30, with returns showing a 3.8% decline over 7 days, a 17.4% decline over 30 days, a 19.3% decline year to date, a 14.2% gain over 1 year and a very large 3 year and 5 year return. Recent coverage around Piper Sandler Companies has focused on its role...
NYSE:HUBS
NYSE:HUBSSoftware

HubSpot (HUBS) Valuation Check After Recent Share Price Rebound And Analyst Discount

HubSpot (HUBS) is back on investor radars after a recent share price move, with the stock closing at $264.30 and showing mixed returns across the past week, month, and past 3 months. See our latest analysis for HubSpot. That 2.59% 1 day share price gain to US$264.30 comes after a 26.26% 30 day share price return. However, the year to date share price return and 1 year total shareholder return are both sharply negative, hinting that recent momentum is more of a rebound than a sustained...
NYSE:U
NYSE:USoftware

Unity Insider Selling Raises Questions As Margins Improve And Growth Slows

Unity Software (NYSE:U) has seen significant insider selling activity while reporting expanding operating margins. At the same time, the company is working through revenue growth challenges that have drawn fresh attention from investors. The mix of insider sales, margin improvement, and pressure on growth is raising new questions about Unity's internal outlook and business direction. For investors watching Unity Software at a share price of $19.43, the recent pattern of insider selling...
NYSE:AXP
NYSE:AXPConsumer Finance

American Express Buyback And Guidance Shift Refocuses Travel Driven Growth

American Express (NYSE:AXP) has launched a $16b share repurchase program, signaling a major round of capital returns to shareholders. The company has also raised its full year 2026 guidance, citing robust travel demand and expansion in its premium cardmember base. International travel volumes have moved above pre pandemic levels and contributed to a 15% rise in total network volume. For you as an investor, this news comes at a time when NYSE:AXP shares trade around $299.96, after a 15.3%...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Walmart’s New Exclusive Launches Test Growth Story And Valuation Premium

Multiple consumer brands have launched new and exclusive products at Walmart stores across the U.S. over the past week. Recent rollouts include Schwarzkopf's KERATÎME haircare, 7 Brew Ready-to-Drink coffee, Red Diamond fresh-brewed sweet tea, Hairitage Next Gen clean haircare, and Liquid Youth Sparkling Collagen Water. These launches expand Walmart's presence in wellness, beauty, and beverage categories with a focus on exclusivity and clean formulations. For investors watching Walmart,...
NYSEAM:IE
NYSEAM:IEMetals and Mining

Ivanhoe Electric Cash Windfall From Alacrán Sale Reshapes Valuation Debate

Cordoba Minerals has completed the sale of its remaining interest in the Alacrán Project in Colombia. As part of the transaction, Cordoba is distributing a substantial amount of cash to shareholders. Ivanhoe Electric (NYSEAM:IE), as a majority shareholder, is set to receive over $58 million in cash. For Ivanhoe Electric, at a current share price of $12.34, this cash inflow comes after a mixed run in the stock. The shares are down 6.0% over the past week and 28.9% over the past month, and...
NasdaqGS:NSIT
NasdaqGS:NSITElectronic

Insight Enterprises (NSIT) Valuation Check After Recent Share Price Weakness

Insight Enterprises (NSIT) has been drawing attention after recent share price pressure, including a 10.2% decline over the past month. This has prompted investors to revisit how its current valuation lines up with underlying fundamentals. See our latest analysis for Insight Enterprises. Putting the recent 10.2% 1 month share price decline in context, Insight Enterprises now sits at US$80.86. The 1 year total shareholder return is 46.6% in the red and multi year total returns are also under...
NYSE:FE
NYSE:FEElectric Utilities

FirstEnergy (FE) Valuation Check After Recent Share Price Momentum And Grid Investment Plans

What recent performance numbers say about FirstEnergy (FE) With no single headline event driving attention, FirstEnergy (FE) is back on investors’ radars after a recent share price move. This interest is supported by reported revenue of US$14.9b and net income of US$1.02b. See our latest analysis for FirstEnergy. At a share price of US$51.16, FirstEnergy has delivered a 6.74% 1 month share price return and a 15.59% 3 month share price return, while the 1 year total shareholder return of...
NasdaqGM:LFMD
NasdaqGM:LFMDHealthcare Services

LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP‑1 Telehealth Offerings

In early March 2026, LifeMD, Inc. reported that it moved from a US$21.41 million annual net loss in 2024 to US$14.35 million net income in 2025, issued double‑digit revenue growth guidance for 2026, and highlighted expanding telehealth offerings including its oral Wegovy weight management launch with Novo Nordisk. This shift to profitability, combined with more than 322,000 active subscribers and growing GLP‑1 and women’s health programs, signals a business model that is scaling across...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

Does The Recent Pullback Make NetApp (NTAP) Look Attractive On Valuation Grounds?

If you are wondering whether NetApp's share price really reflects what the business is worth today, you are not alone. That is exactly what this article will unpack. NetApp shares last closed at US$98.66, with returns of 9.5% over 1 year, 71.3% over 3 years and 58.3% over 5 years. However, the stock has seen a 2.4% decline over 7 days, 6.8% over 30 days and 7.3% year to date. Recent company specific headlines have continued to keep investor attention on NetApp, helping frame how the market...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Is Syndax Pharmaceuticals (SNDX) Pricing Reflect Its 81.5% One Year Share Price Gain

If you are wondering whether Syndax Pharmaceuticals' current share price offers good value, the key question is how that price compares with what the business might be worth. The stock last closed at US$23.50, with returns of 6.5% over 7 days, 8.2% over 30 days, 10.3% year to date and 81.5% over the past year, while the 3 year and 5 year returns stand at 5.6% and 2.4% respectively. Recent attention on Syndax has been driven by ongoing interest in its pipeline and broader sector news that can...
NYSE:CXW
NYSE:CXWCommercial Services

Is It Time To Reconsider CoreCivic (CXW) After Recent Share Price Pullback

If you are wondering whether CoreCivic's share price really reflects what the business is worth, you are not alone. This article is written with that question in mind. CoreCivic's stock closed at US$18.21 most recently, with returns of 0.8% over 7 days, a 1.6% decline over 30 days, a 4.3% decline year to date and a 10.4% decline over the past year, while the 3 year and 5 year returns sit at 102.8% and 97.5% respectively. These mixed returns have put more attention on how the market is...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Johnson And Johnson Bladder Cancer Data Adds Interest To Valuation Story

Johnson & Johnson (NYSE:JNJ) reported strong Phase 1 results for its intravesical erdafitinib drug releasing system in non muscle invasive bladder cancer. The program showed high response rates, durable remission, and an encouraging safety profile in intermediate and high risk patients. The data support moving the Erda iDRS program into late stage development as a localized treatment approach. For investors watching NYSE:JNJ, this update adds a fresh piece of information to the company...
NYSE:FCPT
NYSE:FCPTSpecialized REITs

A Look At Four Corners Property Trust’s Valuation As New Triple Net Acquisitions Support Investor Interest

What FCPT’s latest acquisitions tell you about the business Four Corners Property Trust (FCPT) has been active in March, acquiring a VCA Animal Hospital in Michigan, a Carrabba's Italian Grill in Florida, and two automotive service properties under long term triple net leases. See our latest analysis for Four Corners Property Trust. Against this string of new acquisitions and a recently affirmed dividend, Four Corners Property Trust’s 90 day share price return of 11.19% and 10.33% year to...
NYSE:PRU
NYSE:PRUInsurance

PGIM Awards Put Fresh Focus On Prudential Financial’s Valuation And Mix

PGIM, the global investment management arm of Prudential Financial (NYSE:PRU), received multiple 2026 LSEG Lipper Fund Awards. The awards recognize consistent, risk adjusted performance across PGIM funds. The recognition extends Prudential Financial's record of industry accolades for its asset management platform. For a company often associated first with insurance and annuities, these LSEG Lipper Fund Awards put a spotlight on a different side of Prudential Financial: its global asset...
NasdaqGS:MAPS
NasdaqGS:MAPSSoftware

WM Technology (MAPS) Margin Compression To 1.1% Tests Bullish Earnings Narratives

WM Technology (MAPS) closed out FY 2025 with Q4 revenue of about US$43.1 million and a basic EPS loss of roughly US$0.03, while trailing twelve month EPS stood at around US$0.02 on revenue of roughly US$174.7 million. Over recent periods the company has seen quarterly revenue range between about US$42.2 million and US$47.7 million, with EPS moving from a profit of roughly US$0.03 per share in late 2024 to small profits through most of 2025 before the latest quarterly loss. This has left...
NYSE:DK
NYSE:DKOil and Gas

A Look At Delek US Holdings (DK) Valuation After Its Fourth Quarter 2025 EPS Beat

Delek US Holdings (DK) is back in focus after reporting fourth quarter 2025 adjusted EPS of $2.31 versus a forecast loss of $0.07, even though quarterly revenue trailed expectations. See our latest analysis for Delek US Holdings. Despite a small 1-day share price decline of 0.57% to US$41.72, Delek US Holdings has seen strong recent momentum, with a 30-day share price return of 20.86% and a 1-year total shareholder return of roughly 1.8x. This suggests investors are reassessing its risk and...
NYSE:MC
NYSE:MCCapital Markets

Is It Time To Revisit Moelis (MC) After The Recent Share Price Slump

If you are wondering whether Moelis shares offer good value at today's price, it helps to step back and look at what the current market is implying about the business. The stock last closed at US$51.75, after a 7.8% decline over the past week, a 25.1% decline over the past month, and a 27.3% decline year to date, while still showing a 51.6% return over 3 years and 23.6% over 5 years. These recent moves have kept Moelis on investors' radars, with market commentary often linking advisory firms...
NYSE:UTZ
NYSE:UTZFood

Assessing Utz Brands (UTZ) Valuation After Recent Share Price Pullback

Why Utz Brands Stock Is On Investors’ Radar Utz Brands (UTZ) has drawn fresh attention after a sharp share price pullback, with the stock around $7.56 and showing negative returns over the past month and past 3 months. See our latest analysis for Utz Brands. The recent pullback has been steep, with a 30 day share price return of a 32.08% decline and a 90 day share price return of a 26.10% decline. Over the longer term, the 1 year total shareholder return of a 41.97% decline points to...
NYSE:KEYS
NYSE:KEYSElectronic

How Keysight’s AI Data Center And RF Test Expansion At Keysight Technologies (KEYS) Has Changed Its Investment Story

In early March 2026, Keysight Technologies rolled out a wave of AI-focused test and measurement launches, from 224G and 1.6T data-center interconnect validation tools to the 220 GHz N4378A Lightwave Component Analyzer, alongside new interoperability and RF partnerships with firms including Salience Labs, 3dB Labs, Qualcomm, Samsung, and NVIDIA. Together, these announcements highlight Keysight’s push to become a foundational enabler for AI data centers and advanced wireless networks,...